Call Options

14 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$724.87 - $909.04 $3.26 Million - $4.09 Million
-4,500 Reduced 18.07%
20,400 $18.5 Million
Q1 2024

May 09, 2024

BUY
$592.2 - $792.28 $14.7 Million - $19.7 Million
24,900 New
24,900 $19.4 Million
Q1 2022

May 11, 2022

SELL
$234.69 - $291.66 $8.57 Million - $10.6 Million
-36,500 Reduced 71.71%
14,400 $4.12 Million
Q4 2021

Feb 10, 2022

SELL
$224.85 - $279.04 $24.5 Million - $30.4 Million
-109,000 Reduced 68.17%
50,900 $14.1 Million
Q3 2021

Nov 12, 2021

BUY
$221.6 - $272.71 $21.7 Million - $26.7 Million
98,000 Added 158.32%
159,900 $36.9 Million
Q2 2021

Aug 12, 2021

BUY
$180.55 - $233.54 $2.38 Million - $3.08 Million
13,200 Added 27.1%
61,900 $14.2 Million
Q1 2021

May 17, 2021

BUY
$164.32 - $212.72 $6.23 Million - $8.06 Million
37,900 Added 350.93%
48,700 $9.1 Million
Q3 2020

Nov 13, 2020

SELL
$146.22 - $169.13 $25.6 Million - $29.7 Million
-175,400 Reduced 94.2%
10,800 $1.6 Million
Q2 2020

Aug 12, 2020

BUY
$136.42 - $164.18 $8.76 Million - $10.5 Million
64,200 Added 52.62%
186,200 $30.6 Million
Q1 2020

May 13, 2020

SELL
$119.05 - $147.35 $5.2 Million - $6.44 Million
-43,700 Reduced 26.37%
122,000 $16.9 Million
Q4 2019

Feb 14, 2020

BUY
$106.92 - $132.43 $5.78 Million - $7.16 Million
54,100 Added 48.48%
165,700 $21.8 Million
Q3 2019

Nov 12, 2019

BUY
$106.79 - $116.16 $11.4 Million - $12.4 Million
107,100 Added 2380.0%
111,600 $12.5 Million
Q1 2019

May 10, 2019

SELL
$111.31 - $131.02 $979,528 - $1.15 Million
-8,800 Reduced 66.17%
4,500 $584,000
Q3 2018

Nov 09, 2018

BUY
$85.86 - $107.31 $1.14 Million - $1.43 Million
13,300 New
13,300 $1.43 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $834B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Twin Tree Management, LP Portfolio

Follow Twin Tree Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.